162 related articles for article (PubMed ID: 32397195)
1. The β-Carboline Harmine Induces Actin Dynamic Remodeling and Abrogates the Malignant Phenotype in Tumorigenic Cells.
Le Moigne R; Subra F; Karam M; Auclair C
Cells; 2020 May; 9(5):. PubMed ID: 32397195
[TBL] [Abstract][Full Text] [Related]
2. A tumorigenic actin mutant alters fibroblast morphology and multicellular assembly properties.
Blache U; Silván U; Plodinec M; Suetterlin R; Jakob R; Klebba I; Bentires-Alj M; Aebi U; Schoenenberger CA
Cytoskeleton (Hoboken); 2013 Oct; 70(10):635-50. PubMed ID: 23804571
[TBL] [Abstract][Full Text] [Related]
3. Cell-penetrating peptides with intracellular actin-remodeling activity in malignant fibroblasts.
Delaroche D; Cantrelle FX; Subra F; Van Heijenoort C; Guittet E; Jiao CY; Blanchoin L; Chassaing G; Lavielle S; Auclair C; Sagan S
J Biol Chem; 2010 Mar; 285(10):7712-21. PubMed ID: 20037163
[TBL] [Abstract][Full Text] [Related]
4. Human Costars Family Protein ABRACL Modulates Actin Dynamics and Cell Migration and Associates with Tumorigenic Growth.
Hsiao BY; Chen CH; Chi HY; Yen PR; Yu YZ; Lin CH; Pang TL; Lin WC; Li ML; Yeh YC; Chou TY; Chen MY
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670794
[TBL] [Abstract][Full Text] [Related]
5. Antitumor and neurotoxic effects of novel harmine derivatives and structure-activity relationship analysis.
Chen Q; Chao R; Chen H; Hou X; Yan H; Zhou S; Peng W; Xu A
Int J Cancer; 2005 May; 114(5):675-82. PubMed ID: 15609303
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells.
Tirado OM; Mateo-Lozano S; Villar J; Dettin LE; Llort A; Gallego S; Ban J; Kovar H; Notario V
Cancer Res; 2006 Oct; 66(20):9937-47. PubMed ID: 17047056
[TBL] [Abstract][Full Text] [Related]
7. 4-Hydroxycoumarin disorganizes the actin cytoskeleton in B16-F10 melanoma cells but not in B82 fibroblasts, decreasing their adhesion to extracellular matrix proteins and motility.
Velasco-Velázquez MA; Agramonte-Hevia J; Barrera D; Jiménez-Orozco A; García-Mondragón MJ; Mendoza-Patiño N; Landa A; Mandoki J
Cancer Lett; 2003 Aug; 198(2):179-86. PubMed ID: 12957356
[TBL] [Abstract][Full Text] [Related]
8. Studies on anti-metastatic and anti-invasive effects of harmine using highly metastatic murine B16F-10 melanoma cells.
Hamsa T; Kuttan G
J Environ Pathol Toxicol Oncol; 2011; 30(2):123-37. PubMed ID: 21967457
[TBL] [Abstract][Full Text] [Related]
9. Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro.
Hamsa TP; Kuttan G
Eur J Pharmacol; 2010 Dec; 649(1-3):64-73. PubMed ID: 20858484
[TBL] [Abstract][Full Text] [Related]
10. The actin cytoskeleton-associated protein zyxin acts as a tumor suppressor in Ewing tumor cells.
Amsellem V; Kryszke MH; Hervy M; Subra F; Athman R; Leh H; Brachet-Ducos C; Auclair C
Exp Cell Res; 2005 Apr; 304(2):443-56. PubMed ID: 15748890
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of myeloperoxidase activity by the alkaloids of Peganum harmala L. (Zygophyllaceae).
Bensalem S; Soubhye J; Aldib I; Bournine L; Nguyen AT; Vanhaeverbeek M; Rousseau A; Boudjeltia KZ; Sarakbi A; Kauffmann JM; Nève J; Prévost M; Stévigny C; Maiza-Benabdesselam F; Bedjou F; Van Antwerpen P; Duez P
J Ethnopharmacol; 2014 Jun; 154(2):361-9. PubMed ID: 24746482
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of siRNA nanocapsules targeted against the EWS-Fli1 oncogene in Ewing sarcoma.
Toub N; Bertrand JR; Tamaddon A; Elhamess H; Hillaireau H; Maksimenko A; Maccario J; Malvy C; Fattal E; Couvreur P
Pharm Res; 2006 May; 23(5):892-900. PubMed ID: 16715379
[TBL] [Abstract][Full Text] [Related]
13. EWS-FLI1 regulates a transcriptional program in cooperation with Foxq1 in mouse Ewing sarcoma.
Shimizu R; Tanaka M; Tsutsumi S; Aburatani H; Yamazaki Y; Homme M; Kitagawa Y; Nakamura T
Cancer Sci; 2018 Sep; 109(9):2907-2918. PubMed ID: 29945296
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the oncogenic fusion protein EWS-FLI1 causes G
Zöllner SK; Selvanathan SP; Graham GT; Commins RMT; Hong SH; Moseley E; Parks S; Haladyna JN; Erkizan HV; Dirksen U; Hogarty MD; Üren A; Toretsky JA
Sci Signal; 2017 Oct; 10(499):. PubMed ID: 28974650
[TBL] [Abstract][Full Text] [Related]
15. Regulation of myosin light chain function by BMP signaling controls actin cytoskeleton remodeling.
Konstantinidis G; Moustakas A; Stournaras C
Cell Physiol Biochem; 2011; 28(5):1031-44. PubMed ID: 22178953
[TBL] [Abstract][Full Text] [Related]
16. Suppression of Non-Small Cell Lung Cancer Growth and Metastasis by a Novel Small Molecular Activator of RECK.
Shen J; Wang B; Zhang T; Zhu N; Wang Z; Jin J; He Y; Hu M
Cell Physiol Biochem; 2018; 45(5):1807-1817. PubMed ID: 29510387
[TBL] [Abstract][Full Text] [Related]
17. Role of actin polymerization and adhesion to extracellular matrix in Rac- and Rho-induced cytoskeletal reorganization.
Machesky LM; Hall A
J Cell Biol; 1997 Aug; 138(4):913-26. PubMed ID: 9265656
[TBL] [Abstract][Full Text] [Related]
18. Small-molecule screen identifies modulators of EWS/FLI1 target gene expression and cell survival in Ewing's sarcoma.
Boro A; Prêtre K; Rechfeld F; Thalhammer V; Oesch S; Wachtel M; Schäfer BW; Niggli FK
Int J Cancer; 2012 Nov; 131(9):2153-64. PubMed ID: 22323082
[TBL] [Abstract][Full Text] [Related]
19. Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase A.
Toretsky JA; Erkizan V; Levenson A; Abaan OD; Parvin JD; Cripe TP; Rice AM; Lee SB; Uren A
Cancer Res; 2006 Jun; 66(11):5574-81. PubMed ID: 16740692
[TBL] [Abstract][Full Text] [Related]
20. EWS-FLI1 positively regulates autophagy by increasing ATG4B expression in Ewing sarcoma cells.
Lu Q; Zhang Y; Ma L; Li D; Li M; Li J; Liu P
Int J Mol Med; 2017 Oct; 40(4):1217-1225. PubMed ID: 28902354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
